BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28341062)

  • 1. The effect of post-mastectomy radiation in women with one to three positive nodes enrolled on the control arm of BCIRG-005 at ten year follow-up.
    Tam MM; Wu SP; Perez C; Gerber NK
    Radiother Oncol; 2017 Apr; 123(1):10-14. PubMed ID: 28341062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmastectomy Radiation Therapy in Women with T1-T2 Tumors and 1 to 3 Positive Lymph Nodes: Analysis of the Breast International Group 02-98 Trial.
    Zeidan YH; Habib JG; Ameye L; Paesmans M; de Azambuja E; Gelber RD; Campbell I; Nordenskjöld B; Gutiérez J; Anderson M; Lluch A; Gnant M; Goldhirsch A; Di Leo A; Joseph DJ; Crown J; Piccart-Gebhart M; Francis PA
    Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):316-324. PubMed ID: 29534902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of postmastectomy radiation on locoregional recurrence in breast cancer patients with 1-3 positive lymph nodes treated with modern systemic therapy.
    Tendulkar RD; Rehman S; Shukla ME; Reddy CA; Moore H; Budd GT; Dietz J; Crowe JP; Macklis R
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e577-81. PubMed ID: 22560546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-mastectomy Radiation Therapy in Breast Cancer Patients with Nodal Micrometastases.
    Wu SP; Tam M; Shaikh F; Lee A; Chun J; Schnabel F; Guth A; Adams S; Schreiber D; Oh C; Gerber NK
    Ann Surg Oncol; 2018 Sep; 25(9):2620-2631. PubMed ID: 29987606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal impact of postmastectomy radiation therapy on locoregional recurrence for breast cancer patients with 1 to 3 positive lymph nodes in the modern treatment era.
    Miyashita M; Tada H; Suzuki A; Watanabe G; Hirakawa H; Amari M; Kakugawa Y; Kawai M; Furuta A; Sato K; Yoshida R; Ebata A; Sasano H; Jingu K; Ohuchi N; Ishida T
    Surg Oncol; 2017 Jun; 26(2):163-170. PubMed ID: 28577722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmastectomy radiation and mortality in women with T1-2 node-positive breast cancer.
    Smith BD; Smith GL; Haffty BG
    J Clin Oncol; 2005 Mar; 23(7):1409-19. PubMed ID: 15735117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node-positive breast cancer: a National Cancer Database (NCDB) analysis.
    Rusthoven CG; Rabinovitch RA; Jones BL; Koshy M; Amini A; Yeh N; Jackson MW; Fisher CM
    Ann Oncol; 2016 May; 27(5):818-27. PubMed ID: 26861597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of postmastectomy radiotherapy in women with pathologic T3N0M0 breast cancer.
    Cassidy RJ; Liu Y; Kahn ST; Jegadeesh NK; Liu X; Subhedar PD; Arciero CA; Gillespie TW; Torres MA
    Cancer; 2017 Aug; 123(15):2829-2839. PubMed ID: 28387923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of different lymph node staging systems in predicting prognosis and determining indications for postmastectomy radiotherapy in patients with T1-T2pN1 breast carcinoma.
    Kustić D; Klarica Gembić T; Grebić D; Petretić Majnarić S; Nekić J
    Strahlenther Onkol; 2020 Nov; 196(11):1044-1054. PubMed ID: 32710122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-mastectomy radiotherapy for women with early breast cancer and one to three positive lymph nodes.
    Verma R; Chandarana M; Barrett J; Anandadas C; Sundara Rajan S
    Cochrane Database Syst Rev; 2023 Jun; 6(6):CD014463. PubMed ID: 37327075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Postmastectomy Radiotherapy and Survival Rates for Breast Cancer Patients with T1-T2 and One to Three Positive Lymph Nodes.
    Huo D; Hou N; Jaskowiak N; Winchester DJ; Winchester DP; Yao K
    Ann Surg Oncol; 2015 Dec; 22(13):4295-304. PubMed ID: 25820998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 21-Gene Recurrence Score Assay Predicts Benefit of Post-Mastectomy Radiotherapy in T1-2 N1 Breast Cancer.
    Goodman CR; Seagle BL; Kocherginsky M; Donnelly ED; Shahabi S; Strauss JB
    Clin Cancer Res; 2018 Aug; 24(16):3878-3887. PubMed ID: 29685878
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of postmastectomy radiation therapy in T1-2 breast cancer patients with 1-3 positive axillary lymph nodes.
    Yin H; Qu Y; Wang X; Ma T; Zhang H; Zhang Y; Li Y; Zhang S; Ma H; Xing E; Liu X; Xu Q
    Oncotarget; 2017 Jul; 8(30):49564-49573. PubMed ID: 28484094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of postmastectomy radiotherapy in clinically node-positive, stage II-III breast cancer patients with pathological negative nodes after neoadjuvant chemotherapy: an analysis from the NCDB.
    Liu J; Mao K; Jiang S; Jiang W; Chen K; Kim BY; Liu Q; Jacobs LK
    Oncotarget; 2016 Apr; 7(17):24848-59. PubMed ID: 26709538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locoregional recurrence risk for patients with T1,2 breast cancer with 1-3 positive lymph nodes treated with mastectomy and systemic treatment.
    McBride A; Allen P; Woodward W; Kim M; Kuerer HM; Drinka EK; Sahin A; Strom EA; Buzdar A; Valero V; Hortobagyi GN; Hunt KK; Buchholz TA
    Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):392-8. PubMed ID: 24721590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying factors impacting the efficacy of postmastectomy radiotherapy in patients with early-stage breast cancer and one to two positive lymph nodes.
    Bhutiani N; Egger ME; Stromberg AJ; Bhutiani IK; Ajkay N; McMasters KM
    J Surg Oncol; 2020 Aug; 122(2):128-133. PubMed ID: 32334441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of ECE on the benefits of PMRT for breast cancer patients with positive axillary nodes.
    Geng W; Zhang B; Li D; Liang X; Cao X
    J Radiat Res; 2013 Jul; 54(4):712-8. PubMed ID: 23392824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes in breast cancer patients with ten or more positive axillary nodes treated with combined-modality therapy: the importance of radiation field selection.
    Chang DT; Feigenberg SJ; Indelicato DJ; Morris CG; Lightsey J; Grobmyer SR; Copeland EM; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1043-51. PubMed ID: 17336214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Breast Cancer Patients with T1-2 Tumors and 1-3 Positive Lymph Nodes Treated with or without Postmastectomy Radiation Therapy.
    Gilmore RC; Sebai ME; Psoter KJ; Prasath V; Siotos C; Broderick KP; Jacobs LK; Harvey SC; Habibi M
    Sci Rep; 2020 Jun; 10(1):9887. PubMed ID: 32555240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-mastectomy radiation therapy in breast cancer patients with 1-3 positive lymph nodes: No one size fits all.
    Kayali M; Abi Jaoude J; Tfayli A; El Saghir N; Poortmans P; Zeidan YH
    Crit Rev Oncol Hematol; 2020 Mar; 147():102880. PubMed ID: 32045847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.